Cambivac Ltd

Foot and Mouth disease virus (FMDV) is endemic in most African countries. FMD is a highly infectious and potentially fatal disease that infects livestock. The disease has a huge economic impact in Africa, as it reduces the productivity of farmers and their ability to export produce, with losses conservatively estimated at USD 800 million. There are differ...

PRRS is widely regarded as the most economically important disease in swine, estimated to cost global swine producers in excess of £1billion per annum in production losses alone. These losses are largely the result of a failure to develop and deploy effective vaccines. Cambivac aims to produce vaccines that more effectively control the disease and can res...

This application is for a Development of Prototype (DoP) grant to undertake technology optimisation, scale up, and begin clinical testing of prototype vaccines produced utillising our expression technology which highly efficiently produces improved foot and mouth (FMD) vaccines without the use of live virus. The application builds on a Proof of Concept (P...

This project aims to demonstrate the feasibility of utilising naturally occuring bacteria and phages as the basis of a novel Clostridium difficile (C.diff) therapy as an alternative to antibiotics.

This application is for a Proof of Concept grant to undertake applied research towards a novel approach of applying state-of-the-art genomic analysis, molecular biological and DNA synthesis techniques to the development and deployment of improved attenuated live virus vaccines. The approach aims to identify novel sets of “universal” attenuating mutations ...

This application is for a Proof of Concept grant to see if it is feasible to overcome current technical difficulties with a system that would potentially allow the production of improved foot and mouth (FMD) vaccines without the use of live virus. We propose to use advanced biotechnical techniques that could result in cheaper and more effective vaccines w...

Awaiting Public Summary